Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Pharm Res. 2014 Nov 13;32(5):1663–1675. doi: 10.1007/s11095-014-1565-2

Figure 2. Pharmacokinetic studies of phospho-sulindac in wild-type and Ces1c −/− mice.

Figure 2

Blood levels of phospho-sulindac (P-S) and sulindac in wild-type and Ces1c −/− mice after a single dose of (A) P-S (300mg/kg i.p.), (B) PLA-PEG P-S (50mg/kg, i.v.) and (C) Pluronic P123 P-S (50mg/kg, i.v.), respectively.